Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization

Abstract Background Heterogeneity of liver function and tumor burden in intermediate-stage hepatocellular carcinoma (HCC) results in different outcomes after transarterial chemoembolization (TACE). Easy albumin-bilirubin (EZ-ALBI), a simplified albumin-bilirubin (ALBI) score, has recently been propo...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Prooksa Ananchuensook, Supachaya Sriphoosanaphan, Sirinporn Suksawatamnauy, Nipaporn Siripon, Nutcha Pinjaroen, Nopavut Geratikornsupuk, Stephen J. Kerr, Kessarin Thanapirom, Piyawat Komolmit
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2022-06-01
Serija:	BMC Gastroenterology
Teme:	Easy albumin-bilirubin score Intermediate-stage hepatocellular carcinoma Trans-arterial chemoembolization Overall survival
Online dostop:	https://doi.org/10.1186/s12876-022-02366-y
Oznake:	Označite Brez oznak, prvi označite!